Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05362760
Title Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management (MINERVA)
Acronym MINERVA
Recruitment Recruiting
Gender female
Phase FDA approved
Variant Requirements No
Sponsors Prof. W. Janni
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU | CHE


No variant requirements are available.